Maxion Therapeutics raised €66M in a Series A round in Mar 2025. The company is based in Cambridge, UK. Investors in the round: BGF, British Patient Capital, Eli lilly and company and 4 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
